🇺🇸 FDA
Patent

US 11168325

Methods for treatment of polycystic kidney disease

granted A61KA61K31/713A61K45/06

Quick answer

US patent 11168325 (Methods for treatment of polycystic kidney disease) held by The Board of Regents of the University of Texas System expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/713, A61K45/06, A61P, A61P13/12